{
  "cik": 1842295,
  "cik_padded": "0001842295",
  "entityName": "Maze Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-122778",
      "filed": "2026-03-25",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 794000.0,
        "cash": 189247000.0,
        "eps_diluted": -3.05,
        "free_cash_flow": -112734000.0,
        "net_income": -131120000.0,
        "operating_cash_flow": -111940000.0,
        "operating_income": -142899000.0,
        "stockholders_equity": 354966000.0,
        "total_assets": 397127000.0,
        "total_liabilities": 42161000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.11877475589211361,
        "roa_avg2y": -0.4112478417486188,
        "roa_period_end": -0.3301714564862122,
        "roe_avg2y": -5.989539318913733,
        "roe_period_end": -0.3693874906329057
      }
    },
    {
      "accn": "0001193125-26-122778",
      "filed": "2026-03-25",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1147000.0,
        "cash": 196812000.0,
        "eps_diluted": 1.25,
        "free_cash_flow": 74807000.0,
        "net_income": 52231000.0,
        "operating_cash_flow": 75954000.0,
        "operating_income": 57586000.0,
        "stockholders_equity": -311183000.0,
        "total_assets": 240542000.0,
        "total_liabilities": 43638000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "roa_period_end": "ratio"
      },
      "ratios": {
        "roa_period_end": 0.21713879488821078
      }
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-122778",
    "filed": "2026-03-25",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001842295.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001842295.json"
  },
  "ticker": "MAZE"
}